| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Pharmaceuticals (Health Care sector), SCYX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.36M | - | - | |
| Other | 574.5K | - | - | |
| CFO | 398.5K | - | - | |
| Dir | 12.6K | - | - | |
| Dir | 12.1K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | Angulo Gonzalez David | Chief Medical Officer | Buy | 12,000 | $0.50 | $5,950.80 | +10.9% | |
| Sep 6, 2018 | Angulo Gonzalez David | Chief Medical Officer | Buy | 7,000 | $1.27 | $8,890.00 | +6.9% | |
| Aug 23, 2018 | Taglietti Marco | Chief Executive Officer | Buy | 25,000 | $1.29 | $32,250.00 | +6.2% | |
| Mar 29, 2018 | Angulo Gonzalez David | Chief Medical Officer | Buy | 6,000 | $1.36 | $8,160.00 | +6.3% | |
| Mar 8, 2018 | Hastings David C | Director | Buy | 11,834 | $1.69 | $19,999.46 | +59.2% | |
| Mar 8, 2018 | Francois Eric | Chief Financial Officer | Buy | 5,917 | $1.69 | $9,999.73 | +31.1% | |
| Mar 8, 2018 | Taglietti Marco | Chief Executive Officer | Buy | 100,000 | $1.69 | $169,000.00 | +32.9% | |
| Mar 8, 2018 | Angulo Gonzalez David | Chief Medical Officer | Buy | 14,790 | $1.69 | $24,995.10 | +20.0% | |
| Mar 8, 2018 | Sukenick Scott | General Counsel | Buy | 2,959 | $1.69 | $5,000.71 | New | |
| Mar 8, 2018 | Angulo Gonzalez David | Chief Medical Officer | Buy | 7,000 | $1.39 | $9,730.00 | +7.9% |